Bavarian Nordic is a leading industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases with a large unmet medical need.
Company overview
PROSTVAC™ Prostate cancer vaccine
IMVAMUNE® Smallpox vaccine
All projects
Immunotherapy offers improved treatment options with better quality of life
Prostate cancer Breast cancer
Development of preventative countermeasures against biological weapons
Smallpox Anthrax
Early stage projects in various infectious diseases
HIV Measles/RSV
9 March 2010Today, Bavarian Nordic published its annual report 2009 - conference call today at 09 am (CET) Download report Conference call details and presentation
Subscribe to our mailinglist to receive company announcements and financial reports via e-mail.
